Navigation Links
Dyadic International Extends All Debt Maturity Dates
Date:10/19/2013

JUPITER, Fla., Oct. 18, 2013 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic")(OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, biochemical, biopharmaceutical and industrial enzyme industries, announced today that it has entered into agreements with all of its outstanding promissory note holders to extend their maturity dates to January 1, 2015.  The convertible portion of the debt, representing $6.8 million of the total $8.2 million outstanding principal, may be prepaid by Dyadic at any time in whole or in part, without penalty, after March 31, 2014 with 30 days notice.  In all other respects, the terms and conditions of these promissory notes remain unchanged and in full force and effect.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )

Dyadic's President and Chief Executive Officer, Mark Emalfarb, stated, "The extension of our debt provides Dyadic with greater flexibility by allowing us the option to call the convertible debt early."

About Dyadic

Dyadic is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, biochemical, biopharmaceutical and industrial enzyme industries.

Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 fungus which enables the development and large scale manufacture of low cost proteins and enzymes for diverse market opportunities. The C1 platform technology can also be used to screen for the discovery of novel genes and proteins. Dyadic actively pursues licensing arrangements and other commercial opportunities to levera
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dyadic International Reports Profitable 2012 Full Year Financial Results
2. Dyadic International To Announce Third Quarter 2012 Financial Results And Host Conference Call On Thursday, November 8, 2012
3. Dyadic Netherlands To Develop Enzymes For EU-Funded Research Consortium
4. Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
5. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
6. CIVCO Names Darrell Newcombe as Vice President of International Sales for Radiation Oncology
7. Paul Kauffman of Accident Fund to Present on Identifying Risky Opioid Prescribing Patterns at 99th Annual International Association of Industrial Accident Boards & Commissions Conference
8. Multiple International Breast Cancer Guidelines Confirm Use of Agendia Tests for Prognostic, Predictive Information in Cancer Treatment Decisions
9. Metabolic Solutions Development Company presents Phase 2a clinical trial results at the 14th International Conference on Alzheimers Drug Discovery
10. WIKA Process Solutions, Deer Park, Texas Acquires Gayesco International.
11. PAREXEL International To Present At Robert Baird Healthcare Conference And Raymond James North American Equities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
(Date:7/2/2015)... South Korea, July 2, 2015 ALPINION MEDICAL SYSTEMS ... E-CUBE Series ultrasound system. Developed to enhance user experience ... the E-CUBE 15 EX produces superb image quality. With ... in women,s health, general imaging, and shared service applications. ... latest in the renowned E-CUBE Series, the E-CUBE 15 ...
(Date:7/2/2015)... July 2, 2015   Wilson Therapeutics AB , ... Hans Schikan to its board of directors. The appointment ... Meeting on June 30. "We are delighted ... Jonas Hansson , CEO of Wilson Therapeutics. "Hans ... we look forward to his contributions to the Company." ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
... WALTHAM, Mass., Sept. 23 Interleukin Genetics, ... top-line positive results from a retrospective clinical study on ... study previously reported in the Journal of the American ... following diets matched to their genotype, as determined by ...
... , , NOVATO, Calif., Sept. ... today that the first patient has initiated treatment in the Phase ... the treatment of phenylketonuria (PKU). Initial top-line results are expected in ... program and believe that, if approved, PEG-PAL may offer a significant ...
Cached Medicine Technology:Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss 2Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss 3BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU 2BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU 3
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ... procedures and executing them with care and precision. There is an art and ... has had the honor of successfully reshaping the facial features and lives of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists at the University ... through five federal grants to study a group of related mosquito-borne viruses. The ... , The research will be conducted in the Regional Biocontainment Laboratory (RBL) at ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. Smith, ... retained to lead a national chief executive officer recruitment for Indiana ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of the Gelatin Capsule manufacturers. The report is a valuable source of guidance ... depicts the global and Chinese market for the Gelatin Capsule industry including capacity, ...
(Date:7/2/2015)... Mobile, AL (PRWEB) , ... July 02, 2015 , ... Every year, DUI arrests and ... of July may be the deadliest day of the year when it comes to being ... , “The National Highway Traffic Safety Association reports that 40% of all highway deaths between ...
Breaking Medicine News(10 mins):Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Attorney David Maloney Stresses Safety through Sobriety 2
... with depression, bipolar disorders could receive more targeted treatment ... types of imaging techniques enable researchers to map brain ... in depression, bipolar disorder and other mood disorders, and ... these techniques was expected to be presented Tuesday during ...
... to Secondhand Smoke,in the Nation,s Capitol, Statement of ... 6 On behalf of the American,Lung Association, I ... (D-OH), Dick Durbin (D-IL) and Jack Reed (D-RI) for,their ... in the,Senate. For too long, Senators, staff and visitors ...
... XM Satellite Radio announced today,the second annual ... Sam,s Club raise $10 million in May for ... and improving the,lives of children at hospitals across ... The XMKiDS Traveling Roadshow will kick-off on ...
... France, May 6 NicOx S.A.,(Euronext Paris: COX) ... 2 study,conducted by its partner Pfizer Inc, which ... PF-03187207 to Xalatan(R) (latanoprost) 0.005% in,patients with primary ... PF-03187207 demonstrated a clinically significant reduction,in diurnal intraocular ...
... into melanoma by showing the interaction of two key ... Penn State scientists also demonstrate that therapeutic targeting of ... this deadly form of cancer. , "We have shown ... communicate with one another in a mole, they cooperate ...
... Health Inc. (TSX: DAX),(Nasdaq: DRAX ) will report ... Friday May 9, 2008., Annual and Special Meeting ... "Meeting") of shareholders of,DRAXIS is scheduled to be held ... Bank Tower, Toronto, Ontario, Canada on Friday, May 23, ...
Cached Medicine News:Health News:Imaging Advances Map Brain Areas Affecting Mood 2Health News:Imaging Advances Map Brain Areas Affecting Mood 3Health News:American Lung Association Hails Decision to Snuff Out Smoking in U.S. Senate Lounges 2Health News:XM Launches Second Annual 'XMKiDS Traveling Roadshow' National Initiative Benefiting Children's Miracle Network 2Health News:XM Launches Second Annual 'XMKiDS Traveling Roadshow' National Initiative Benefiting Children's Miracle Network 3Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 2Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 3Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 4Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 5Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 6Health News:Scientists identify interacting proteins key to melanoma development, treatment 2Health News:Scientists identify interacting proteins key to melanoma development, treatment 3Health News:DRAXIS to Report First Quarter Results on May 9th 2Health News:DRAXIS to Report First Quarter Results on May 9th 3Health News:DRAXIS to Report First Quarter Results on May 9th 4
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
... Tip flattened and angled 90 1.0mm from end, ... lock high pressure extension tubing set, Capable of ... OD- 1.5mm (.06 in) long luer lock, high ... tubing. Bend 1.0mm from end. (Cannulas ...
Rounded tip for even incisions reducing post-op astigmatism...
Stab incision blades color coded for simple and accurate identification...
Medicine Products: